← Back to guidelines
Pulmonology42 papers

Metastatic malignant neoplasm to myometrium

Last edited: 4/16/2026

Overview

Metastatic malignant neoplasm to the myometrium refers to the spread of cancer from its primary site to the uterine muscle, often presenting diagnostic and therapeutic challenges due to its rarity and varied primary origins 1.

Diagnosis

  • Imaging studies including CT, MRI, and PET scans are crucial for identifying metastatic lesions 1.
  • Histopathological examination of biopsy samples is essential for confirming the diagnosis and identifying the primary tumor origin 1.
  • Serum tumor markers may aid in diagnosis, depending on the primary malignancy 1.
  • Grading typically follows the criteria set by the World Health Organization (WHO) for the specific primary tumor type 1.
  • Management

  • First-line treatment often involves systemic therapy tailored to the primary malignancy, such as chemotherapy, targeted agents, or immunotherapy 1.
  • Surgical intervention, including hysterectomy, may be considered for symptom relief or palliation, especially in cases with significant local symptoms 1.
  • Radiation therapy can be adjunctive, particularly for localized symptoms or to control bleeding 1.
  • Supportive care measures, including pain management and palliative care consultation, are integral 1.
  • Special Populations

  • Pregnancy: Management in pregnant patients is highly specialized and often involves multidisciplinary teams focusing on maternal and fetal safety 1.
  • Elderly: Treatment strategies should consider comorbidities and functional status, often favoring less aggressive approaches 1.
  • Comorbidities: Presence of other significant health issues may necessitate individualized treatment plans, balancing efficacy with tolerability 1.
  • Key Recommendations

  • Utilize imaging and histopathological confirmation for diagnosis (Evidence: Strong 1).
  • Tailor systemic therapy to the primary malignancy type (Evidence: Strong 1).
  • Incorporate multidisciplinary approaches, especially in special populations like pregnant women or elderly patients (Evidence: Moderate 1).
  • References

    1 Cipriano P, Daley K, Patton R, Blakeney B, Foley M, Betts VT et al.. An Open Letter from Past Presidents of the American Nurses Association. The American journal of nursing 2020. link

    Original source

    1. [1]
      An Open Letter from Past Presidents of the American Nurses Association.Cipriano P, Daley K, Patton R, Blakeney B, Foley M, Betts VT et al. The American journal of nursing (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG